US Broker Ratings

Pfizer, Inc. (PFE) Stock Analysis: Unpacking a 15.20% Upside Potential Amidst Market Challenges

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to be a focal point for investors seeking stability in an otherwise volatile market. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Investor Outlook: Navigating Growth with a 20.10% Revenue Surge

Dr. Reddy’s Laboratories Ltd (RDY) stands at an intriguing juncture for investors, driven by its robust position in the healthcare sector and a remarkable 20.10% revenue growth. As an established..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unveiling a 37.87% Potential Upside for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA) stands as a formidable player in the healthcare sector, specializing in the development, manufacturing, and distribution of generic and specialty medicines. Headquartered in Tel..

Align Technology, Inc. (ALGN): Investor Outlook Reveals 18% Upside Potential Amid Market Volatility

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, specializes in medical instruments and supplies. The company, headquartered in Tempe, Arizona, is renowned for its innovative Invisalign..

Incyte Corporation (INCY) Stock Analysis: Evaluating Its Potential Upside and Strong Revenue Growth

Investors eyeing the healthcare sector may want to take a closer look at Incyte Corporation (NASDAQ: INCY), a powerhouse in the biotechnology industry with a market cap of $13.25 billion...

Amgen Inc. (AMGN): Investor Outlook Shows Promising 5.37% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector and a leading player in the drug manufacturing industry, offers compelling investment prospects for individual investors. With a robust market..

BeOne Medicines Ltd. (ONC): Consensus and Growth Potential in the Biotech Sector

Investors with an eye for biotechnology stocks are closely watching BeOne Medicines Ltd. (ONC), a Swiss-based oncology company that’s making waves with its innovative cancer treatments. With a significant market..

Solventum Corporation (SOLV) Stock Analysis: Assessing Growth Potential in the Healthcare Sector

Solventum Corporation (SOLV), a burgeoning player in the healthcare sector, has been attracting attention with its diverse portfolio and strategic approach to addressing critical patient needs globally. With a current..

AptarGroup, Inc. (ATR) Stock Analysis: A Look at Healthcare Sector’s Hidden Gem with 8.67% Upside

AptarGroup, Inc. (NYSE: ATR) might not be the most talked-about name on Wall Street, but for investors eyeing the healthcare sector, this Crystal Lake, Illinois-based company offers a compelling opportunity...

Sanofi (SNY) Investor Outlook: Exploring a 32% Upside Potential with Strong Dividend Yield

Sanofi (SNY), a cornerstone of the global healthcare sector, presents a compelling investment narrative with its robust dividend yield and significant upside potential. Headquartered in Paris, France, Sanofi operates as..

Investor Outlook: Zoetis Inc. (ZTS) Eyes 22.53% Upside with Strong Analyst Consensus

Zoetis Inc. (NYSE: ZTS), a leading global animal health company, stands out in the healthcare sector with a robust market capitalization of $70.87 billion. Specializing in the discovery, development, and..

argenx SE (ARGX) Stock Analysis: Unraveling a 42% Potential Upside with Robust Growth Prospects

argenx SE (NASDAQ: ARGX) is carving out its niche in the biotechnology sector with a focus on developing therapies for autoimmune diseases. Headquartered in the Netherlands, this commercial-stage biopharma company..

Quest Diagnostics (DGX): Analyst Consensus and Growth Potential in the Healthcare Sector

Quest Diagnostics Incorporated (NYSE: DGX), a leading player in the healthcare sector, stands out as a key entity in the diagnostics and research industry. Headquartered in Secaucus, New Jersey, the..

Tempus AI, Inc. (TEM) Stock Analysis: Exploring the 9.37% Potential Upside Despite Valuation Challenges

Tempus AI, Inc. (NASDAQ: TEM), a healthcare technology leader, commands a formidable presence in the health information services sector. With a market capitalization of $10.56 billion, this Chicago-based innovator is..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating Growth Potential Amidst Healthcare Sector Dynamics

Cardinal Health, Inc. (NYSE: CAH) is a stalwart in the healthcare sector, providing comprehensive healthcare services and products both in the U.S. and internationally. With a market capitalization of $39.36..

Boston Scientific Corporation (BSX) Stock Analysis: A Strong Buy with 12.68% Upside Potential

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector, specifically in the medical devices industry, is capturing the attention of investors with its compelling growth metrics and bullish..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Robust 24% Upside Potential Catches Investor Eyes

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a key player in the healthcare sector, specializes in developing pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders. The company, with a market cap of $12.78..

Eli Lilly (LLY) Stock Analysis: Assessing a 21.94% Potential Upside Amidst Strong Revenue Growth

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector renowned for its innovative pharmaceutical offerings, is capturing investor attention with a robust market cap of $700.84 billion...

Koninklijke Philips N.V. (PHG) Stock Analysis: Unlocking a Potential 31.43% Upside in the Healthcare Sector

Koninklijke Philips N.V. (PHG), a renowned name in the healthcare sector, stands as a key player in the medical devices industry. Headquartered in Amsterdam, Netherlands, Philips has a rich history..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant with a 9.09% Upside Potential

Investors exploring opportunities in the healthcare sector might find Cencora, Inc. (NYSE: COR) a compelling prospect. Formerly known as AmerisourceBergen Corporation, Cencora has established itself as a formidable force in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds